Raphael Pharmaceutical (RAPH) Common Equity (2020 - 2025)
Raphael Pharmaceutical's (RAPH) quarterly Common Equity came in at -$1.4 million in Q4 2025, down 93.13% year-on-year from -$20.8 million in Q4 2024, and down 13.37% quarter-over-quarter from -$1.3 million in Q3 2025.
Raphael Pharmaceutical (RAPH) Common Equity (2020 - 2025) Analysis & Trends
Raphael Pharmaceutical has disclosed Common Equity across 6 years of filings, most recently posting -$1.4 million for Q4 2025.
- Common Equity for Q4 2025 came in at -$1.4 million, down 93.13% year-over-year; the trailing twelve-month figure through Dec 2025 was -$1.4 million (down 93.13% YoY), and the FY2025 annual result was -$1.4 million, down 93.13% from the prior year.
- Common Equity came in at -$1.4 million for Q4 2025 at Raphael Pharmaceutical, down from -$1.3 million in the prior quarter.
- In the past five years, Common Equity ranged from a high of $191000.0 in Q2 2021 to a low of -$1.4 million in Q4 2025.
- The 5-year median for Common Equity is -$89000.0 (2023), against an average of -$305350.0.
- Across the five-year window, Common Equity surged 397.67% in 2021 and plunged 1044.44% in 2024, its largest moves.
- Raphael Pharmaceutical's Common Equity stood at $128000.0 in 2021, then slipped by 17.19% to $106000.0 in 2022, then advanced by 0.94% to $107000.0 in 2023, then sank by 793.46% to -$742000.0 in 2024, then tumbled by 93.13% to -$1.4 million in 2025.
- The last three Common Equity figures came in at -$1.4 million (Q4 2025), -$1.3 million (Q3 2025), and -$1.0 million (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | 8.23 Bn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 3.23 Bn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | 5.90 Bn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | 407.18 Mn |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 3.41 Bn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | 6.50 Bn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | 1.75 Bn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | 446.17 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 1.21 Bn |
| 10 | Raphael Pharmaceutical | - | - | - | -1.43 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -1.43 Mn |
| Sep 30, 2025 | -1.26 Mn |
| Jun 30, 2025 | -1.05 Mn |
| Mar 31, 2025 | -734,000.00 |
| Dec 31, 2024 | -742,000.00 |
| Sep 30, 2024 | -616,000.00 |
| Jun 30, 2024 | -290,000.00 |
| Mar 31, 2024 | -103,000.00 |
| Dec 31, 2023 | 107,000.00 |
| Sep 30, 2023 | -75,000.00 |
| Jun 30, 2023 | -61,000.00 |
| Mar 31, 2023 | -9,000.00 |
| Dec 31, 2022 | 106,000.00 |
| Sep 30, 2022 | -62,000.00 |
| Jun 30, 2022 | 118,000.00 |
| Mar 31, 2022 | 103,000.00 |
| Dec 31, 2021 | 128,000.00 |
| Sep 30, 2021 | -125,000.00 |
| Jun 30, 2021 | 191,000.00 |
| Mar 31, 2021 | -298,000.00 |